Ciaran D. Scallan

4.4k total citations · 2 hit papers
28 papers, 3.2k citations indexed

About

Ciaran D. Scallan is a scholar working on Genetics, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Ciaran D. Scallan has authored 28 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 9 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in Ciaran D. Scallan's work include Virus-based gene therapy research (13 papers), Viral gastroenteritis research and epidemiology (8 papers) and CAR-T cell therapy research (8 papers). Ciaran D. Scallan is often cited by papers focused on Virus-based gene therapy research (13 papers), Viral gastroenteritis research and epidemiology (8 papers) and CAR-T cell therapy research (8 papers). Ciaran D. Scallan collaborates with scholars based in United States, Ireland and Canada. Ciaran D. Scallan's co-authors include Linda B. Couto, Katherine A. High, Roland W. Herzog, Alan McClelland, Tongyao Liu, Alan W. Flake, Peter J. Larson, Erik D. Skarsgard, Shing Jen Tai and Mark A. Kay and has published in prestigious journals such as The Lancet, Nature Communications and Nature Genetics.

In The Last Decade

Ciaran D. Scallan

28 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector

2000 782 citations Mark A. Kay, Catherine S. Manno et al. Nature Genetics profile →
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B

2003 578 citations Catherine S. Manno, S Hutchison et al. Blood profile →

Peers

Countries citing papers authored by Ciaran D. Scallan

Since Specialization

Citations

This map shows the geographic impact of Ciaran D. Scallan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciaran D. Scallan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciaran D. Scallan more than expected).

Fields of papers citing papers by Ciaran D. Scallan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ciaran D. Scallan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciaran D. Scallan. The network helps show where Ciaran D. Scallan may publish in the future.

Co-authorship network of co-authors of Ciaran D. Scallan

This figure shows the co-authorship network connecting the top 25 collaborators of Ciaran D. Scallan. A scholar is included among the top collaborators of Ciaran D. Scallan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ciaran D. Scallan. Ciaran D. Scallan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential shaping of T cell responses elicited by heterologous ChAd68/self-amplifying mRNA SIV vaccine in macaques in combination with αCTLA4, αPD-1, or FLT3R agonist 2025 ·The Journal of Immunology ·Amy Rappaport, Elena Bekerman, (unknown), (unknown), Brian Carr, Cesar A. Corzo, (unknown), (unknown), Ciaran D. Scallan, Romas Geleziunas, Devi SenGupta, Karin Jooss	1
2	Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection 2022 ·Nature Communications ·Amy Rappaport, (unknown), Ciaran D. Scallan, Leonid Gitlin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Annie Shen, (unknown), Anne van Abbema, (unknown), Karin Jooss	33
3	Abstract 4159: Lower doses of self-amplifying mRNA drive superior neoantigen-specific CD8 T cell responses in cancer patients versus high doses 2022 ·Cancer Research ·Christine D. Palmer, Amy Rappaport, Meghan G. Hart, (unknown), Sonia Kounlavouth, (unknown), (unknown), (unknown), Annie Shen, (unknown), (unknown), Ciaran D. Scallan, Sue‐Jean Hong, Leonid Gitlin, Alexander I. Spira, Chrisann Kyi, Daniel V.T. Catenacci, Raphaël F. Rousseau, Andrew L. Ferguson, Karin Jooss	1
4	Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats 2018 ·Vaccine ·(unknown), Ciaran D. Scallan, Roberto Mateo, Robert B. Belshe, Sean N. Tucker, Anne Moore	21
5	Oral Modeling of an Adenovirus-Based Quadrivalent Influenza Vaccine in Ferrets and Mice 2016 ·Infectious Diseases and Therapy ·Ciaran D. Scallan, Jonathan D. Lindbloom, Sean N. Tucker	7
6	An Adenovirus-Based Vaccine with a Double-Stranded RNA Adjuvant Protects Mice and Ferrets against H5N1 Avian Influenza in Oral Delivery Models 2012 ·Clinical and Vaccine Immunology ·Ciaran D. Scallan, (unknown), Jonathan D. Lindbloom, (unknown), Sean N. Tucker	57
7	Oral adenoviral-based vaccines: historical perspective and future opportunity 2008 ·Expert Review of Vaccines ·Sean N. Tucker, (unknown), Ciaran D. Scallan	31
8	Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy 2006 ·Blood ·Haiyan Jiang, Linda B. Couto, Susannah Patarroyo‐White, Tongyao Liu, Dea Nagy, Joseph Vargas, Shangzhen Zhou, Ciaran D. Scallan, Jürg M. Sommer, Sharmila Vijay, Federico Mingozzi, Katherine A. High, Glenn F. Pierce	276
9	Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs 2006 ·Blood ·Haiyan Jiang, David Lillicrap, Susannah Patarroyo‐White, Tongyao Liu, Xiaobing Qian, Ciaran D. Scallan, Sandra Powell, (unknown), (unknown), Andrea Labelle, Dea Nagy, Joseph Vargas, Shangzhen Zhou, Linda B. Couto, Glenn F. Pierce	169
10	Novel Caprine Adeno-Associated Virus (AAV) Capsid (AAV-Go.1) Is Closely Related to the Primate AAV-5 and Has Unique Tropism and Neutralization Properties 2005 ·Journal of Virology ·(unknown), Michael A. Lochrie, Shangzhen Zhou, Jennifer Wellman, Ciaran D. Scallan, Mohammad M. Doroudchi, Britta Randlev, Susannah Patarroyo‐White, Tongyao Liu, Peter H. Smith, Howard D. Lehmkuhl, (unknown), Glenn F. Pierce, Peter Colosi	66
11	AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B breakdown → 2003 ·Blood ·Catherine S. Manno, (unknown), S Hutchison, Peter J. Larson, Roland W. Herzog, (unknown), Shing Jen Tai, Margaret V. Ragni, Alexis A. Thompson, Margareth C. Ozelo, Linda B. Couto, Debra G. B. Leonard, Freddie A. Johnson, Alan McClelland, Ciaran D. Scallan, Erik D. Skarsgard, Alan W. Flake, Mark A. Kay, Katherine A. High, Bertil Glader	578
12	Structural and Functional Aspects of Three Major Glycoproteins of the Human Milk Fat Globule Membrane 2001 ·Advances in experimental medicine and biology ·Jerry A. Peterson, Ciaran D. Scallan, Roberto Ceriani, Margit Hamosh	41
13	Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector breakdown → 2000 ·Nature Genetics ·Mark A. Kay, Catherine S. Manno, Margaret V. Ragni, Peter J. Larson, Linda B. Couto, Alan McClelland, Bertil Glader, (unknown), Shing Jen Tai, Roland W. Herzog, Valder R. Arruda, Fred M. Johnson, Ciaran D. Scallan, Erik D. Skarsgard, Alan W. Flake, Katherine A. High	782
14	Protective function of human milk: The milk fat globule 1999 ·Seminars in Perinatology ·(unknown), Jerry A. Peterson, Theresa R. Henderson, Ciaran D. Scallan, (unknown), Roberto Ceriani, Martine Armand, (unknown), Paul Hamosh	106
15	Role of human-milk lactadherin in protectoin against symptomatic rotavirus infection 1998 ·The Lancet ·David S. Newburg, Jerry A. Peterson, Guillermo M. Ruiz‐Palacios, David O. Matson, Ardythe L. Morrow, Justine Shults, (unknown), Prasoon Chaturvedi, (unknown), Ciaran D. Scallan, Michael R. Taylor, (unknown), Larry K. Pickering	261
16	Milk Fat Globule Glycoproteins in Human Milk and in Gastric Aspirates of Mother's Milk-Fed Preterm Infants 1998 ·Pediatric Research ·Jerry A. Peterson, Margit Hamosh, Ciaran D. Scallan, Roberto Ceriani, Theresa R. Henderson, Nitin Mehta, Martine Armand, Paul Hamosh	80
17	Lactadherin (Formerly BA46), a Membrane-Associated Glycoprotein Expressed in Human Milk and Breast Carcinomas, Promotes Arg-Gly-Asp (RGD)-Dependent Cell Adhesion 1997 ·DNA and Cell Biology ·Michael R. Taylor, Joseph Couto, Ciaran D. Scallan, R. L. Ceriani, Jerry A. Peterson	119
18	HUMAN MILK FAT GLOBULE (MFG) GLYCOPROTEINS ARE PRESENT IN GASTRIC ASPIRATES OF HUMAN MILK-FED PRETERM INFANTS. ▴ 739 1996 ·Pediatric Research ·Jerry A. Peterson, Theresa R. Henderson, Ciaran D. Scallan, (unknown), Nitin Mehta, Michael R. Taylor, R. L. Ceriani, Margit Hamosh	3
19	HUMAN MILK LACTADHERIN: NATURE OF ITS CARBOHYDRATE LINKAGE AND PROTECTION AGAINST SYMPTOMATIC ROTAVIRUS INFECTION. ▴ 1779 1996 ·Pediatric Research ·David S. Newburg, Jerry A. Peterson, Guillermo M. Ruiz‐Palacios, David O. Matson, Ardythe L. Morrow, G. Ya. Wiederschain, Prasoon Chaturvedi, (unknown), Ciaran D. Scallan, Michael R. Taylor, (unknown), R. L. Ceriani, (unknown)	4
20	LACTADHERIN, A MEMBRANE-ASSOCIATED ADHESION MOLECULE IN HUMAN MILK.† 381 1996 ·Pediatric Research ·Jerry A. Peterson, Joseph Couto, Michael R. Taylor, Ciaran D. Scallan, Roberto Ceriani	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact